Sanjay Gupta will be at it again, airing Weed 2, his second, hour-long special on the health benefits of cannabis. Michigans medical-pot advocates say it could be a second bombshell in the national debate on pot. We think itll be another big deal across our country, and hopefully even in other parts of the world where they are thinking about changing their laws, said Heidi Parikh of Romulus, founder of the Michigan Compassion education groups that meet in Royal Oak and Southgate. Gupta, who grew up in Novi and graduated from the University of Michigan School of Medicine, will narrate the show, which will include sick youngsters and their parents struggling to obtain cannabis against legal barriers placed by state and federal authorities. If you want to understand the science, this is something youll want to watch, Gupta told the Free Press on Monday. The drug continues to be unfairly rejected by most of the American medical establishment and by government drug regulators, he said. My sense as a doctor is that people have an option now, something that actually was an option up until the 1940s (when the federal government made marijuana illegal). Theres a lot of evidence now that this not only works for many ailments but it often works where nothing else has, he said. The show will discuss how cannabis can ease symptoms of epilepsy, multiple sclerosis, arthritis, cancer and other diseases. As a father as well as a brain surgeon and medical professor, Gupta said he remains opposed to exposing young people to marijuana. And he hedged when asked about legalization for recreational use, calling that an issue for a future show. But he said medical cannabis clearly has a key role to play in seizure disorders, the safe alleviation of pain and numerous other health applications. Last week, the Medical Marijuana New Conditions Review Board in Lansing approved one new use for medical marijuana, post-traumatic stress disorder (PTSD), while denying applications that it be allowed for insomnia and bipolar disorder.
Healthcare Executive Dr. Thomas Wenkart Joins Targeted Medical Pharma’s Board of Directors
Thomas Wenkart, Chief Executive and Chairman at Macquarie Health Corporation, has joined the companys board of directors. A nationally respected expert in healthcare, medical and hospital administration in Australia, Dr. Wenkart established Macquarie Health Corporation in Sydney, Australia, in 1976. His organization owns and operates eleven private hospitals in Australia, and is one of the nation’s leading providers of healthcare services. Dr. Wenkart is a graduate of the Sydney University School of Medicine. In 1976, he established the Health Care Research Institute and the Wenkart Foundation, which supports the Arts and Health Sciences with the credo of community benefits in the shortest possible time. In 2007, the Wenkart Foundation established the Wenkart Chair of Endothelium Medicine at Sydney University and the Centenary Institute. Dr. Wenkart has a unique understanding and interest in medical computing, electronic health records, biomedical technology, and videodermoscopy systems. In 2003, he acquired Derma Medical Systems in Austria. We are very pleased to have Dr. Wenkart join our company. He brings a great deal of healthcare and business experience to our board, said Dr. William Shell, Chief Executive Officer and Chief Science Officer at Targeted Medical Pharma.